CTOs on the Move

Cache Valley Specialty Hospital

www.cvsh.com

 
Cache Valley Specialty Hospital is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Cache Valley Specialty Hospital is based in Logan, UT. You can find more information on Cache Valley Specialty Hospital at www.cvsh.com
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.cvsh.com
  • 2380 N 400 E
    Logan, UT USA 84341
  • Phone: 435.713.9700

Executives

Name Title Contact Details

Similar Companies

Sarasota Memorial Hospital

Sarasota Memorial Hospital is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Sarasota, FL. To find more information about Sarasota Memorial Hospital, please visit www.smh.com

Evolus

Evolus is a performance beauty company with a customer-centric approach focused on delivering breakthrough products. At Evolus, you have the opportunity to be part of a movement. A performance beauty company changing the game. We are bringing innovation and forward-thinking technology to an industry desperately wanting frictionless experiences. Our work disrupts the status quo, but most importantly, we will make an impact, we are customer-centric - always. Because of this, we are excited to step through the door each morning. We help each other climb; we don`t climb over one another. We believe that integrity and a team-driven environment connect entrepreneurial minds. Getting goose bumps? Good. Join the Evolus movement, and let`s see where you can put your talents to work.

Oak Hill Hospital

Oak Hill Hospital is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Oak Hill Hospital is based in Brooksville, FL. You can find more information on Oak Hill Hospital at www.oakhillhospital.com

Nolato Group

Nolato Group is a Baldwin, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cardionomic

Unlike traditional approaches that only address symptoms, Cardionomic addresses the conditions root cause of reduced contractility. The therapy uses neuromodulation to benignly increase contractility, thus improving cardiac output therefore increasing renal flow and end organ perfusion. Benignly increasing contractility decreases negative hormonal signaling, and improves in-hospital morbidity/mortality. This breakthrough therapy is also expected to increase pharmacological tolerance at discharge, which will reduce costly readmission and extend life. Spun off from Denali Medical II, a New Enterprise Associates (NEA) backed incubator, Cardionomic is funded by NEA, Greatbatch Medical and Cleveland Clinic Foundation.